Bridging Science & Decision Strategy for Biologically Complex Health Innovation
We help leadership, R&D, and innovation teams determine what current science can responsibly support, where uncertainty remains, and what additional evidence would materially improve decision confidence.
Evidence Synthesis & Scientific Communication
Focused scientific synthesis to determine what current evidence responsibly supports, and where meaningful uncertainty or validation gaps remain, across product concepts, claims and development pathways.
Applied Biological & Systems Insight
Strategic guidance for microbiome and biologically complex products, integrating mechanistic insight, bioinformatics, and experimental feasibility constraints to support efficient R&D decisions.
Translational R&D Strategy & Due Diligence
Independent scientific judgment to support high-stakes decisions involving translational risk, claims readiness, or strategic direction— before regulatory or commercial commitments are made.
Decision Support Across Translational Risk
We help leadership, R&D, and innovation teams make careful, evidence-informed decisions at critical inflection points: when determining what current science reasonably supports, how findings translate across systems, and what additional data are needed to move forward with confidence.
Our work emphasizes clarity, restraint, and judgment, rather than advocacy or over-interpretation.
